Table 2

Number of interactions, proportion and 95% CI for primary and secondary outcomes, by SP case

Adult (percentage (95% CI))Paediatric (percentage (95% CI))Total (percentage (95% CI))
URIDiarrhoeaFeverURIDiarrhoeaFever
No of SP interactions2502592522522502591522
Any medication85 (79.8, 89)91.1 (86.8, 94.2)85.3 (80.2,89.3)51.6 (45.2, 57.9)32.4 (26.8, 38.6)81.9 (76.5,86.2)71.3 (69, 73.6)
Mean no of medicines dispensed (range)0.89 (0, 2)1.1 (0, 3)1 (0, 3)0.59 (0, 2)1.15 (0,3)0.85 (0, 2)0.79 (0, 3)
Any antibiotic4.35 (2.3, 7.86)4.63 (2.53, 8.16)3.97 (2.03, 7.4)0 (0, 1.87)7.91 (5.02, 12.1)0.77 (0.14, 3.06)3.6 (2.75, 4.69)
Schedule H drug78.7 (73, 83.4)89.2 (84.6, 92.6)61.1 (54.8, 67.1)26.6 (21.3, 32.6)20.6 (15.9, 26.2)7.72 (4.9, 11.9)47.3 (44.8, 45)
Schedule H1 drug1.19 (0.31, 3.71)0 (0, 1.82)0 (0, 1.87)0 (0, 1.87)0 (0, 1.87)0.77 (0.13, 3.06)0.33 (0.12, 0.81)
% of interactions with acceptable management85 (79.8, 89)0 (0, 1.82)1.19 (0.31, 3.73)75.4 (69.5, 80.5)0 (0, 1.87)3.86 (1.97, 7.2)33.3 (30.1 35.7)
  • SP, standardised patient; URI, upper respiratory tract infection.